Janus Henderson Global Life Sciences Fund Class S (JFNSX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
77.24
+0.14 (0.18%)
Feb 13, 2026, 4:00 PM EST

JFNSX Holdings Information

JFNSX is a mutual fund with a total of 106 individual holdings. The top holdings are Eli Lilly and Company stock at 9.54%, Johnson & Johnson at 5.36%, AstraZeneca at 4.30%, UnitedHealth Group at 3.39%, and AbbVie at 3.27%.

Total Holdings
106
Top 10 Percentage
38.59%
Asset Class
Equity
Fund Category
Health
Assets
5.40B
Forward PE Ratio
20.38

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company9.54%477,302
2JNJJohnson & Johnson5.36%1,394,691
3LON: AZNAstraZeneca PLC4.30%1,251,309
4UNHUnitedHealth Group Incorporated3.39%552,603
5ABBVAbbVie Inc.3.27%772,523
6ARGXargenx SE2.86%168,691
7ABTAbbott Laboratories2.74%1,142,504
8BSXBoston Scientific Corporation2.42%1,283,701
9EPA: SANSanofi2.38%1,286,385
10TMOThermo Fisher Scientific Inc.2.34%213,352
11ISRGIntuitive Surgical, Inc.2.30%216,338
12AMGNAmgen Inc.2.28%355,859
13NVSN.MXNovartis AG ADR2.26%933,351
14HCAHCA Healthcare, Inc.2.14%226,201
15BBIOBridgeBio Pharma, Inc.1.99%1,489,071
16VRTXVertex Pharmaceuticals Incorporated1.94%240,773
17RVMDRevolution Medicines, Inc.1.89%1,305,695
18PRAXPraxis Precision Medicines, Inc.1.81%496,468
19DHRDanaher Corporation1.76%418,310
20SYKStryker Corporation1.73%250,330
21SWX: ROGRoche Holding AG1.69%238,191
22RNAAvidity Biosciences, Inc.1.58%1,183,459
23CVSCVS Health Corporation1.51%1,009,160
24ASNDAscendis Pharma A/S1.49%378,372
25MDGLMadrigal Pharmaceuticals, Inc.1.46%132,095
Showing 25 of 106 holdings
Subscribe to see the full list
As of Nov 30, 2025